HOME

THE FIRST LINE OF VERSATILE, PERSONALISED

ANTIMICROBIAL, ANTIVIRAL
AND ANTI-INFLAMMATORY COATINGS

FOR MEDICAL DEVICES

FOR DAILY USE*

*Shown to inactivate SARS-CoV-2 (Covid-19)

Hospital Acquired Infections
0 %
of the cases are related with medical devices.

SPARTHA Medical has developed multifunctional coatings that can prevent
device related infection and diminish inflammation

without affecting the function of the  medical device.
We offer customised coating development for producers with specific properties optimized for the target microenvironment
We develop a « coating kit » to be utilized directly in hospitals with respect to the patient immunoprofile
We develop a biocompatible spray for general/daily use

OUR STORY

SPARTHA Medical is a spin-off from INSERM UMR1121
a public research institute with more than 20 years of experience in development of coating.

SPARTHA Medical ’s core technologies
are based patented inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.

OUR TEAM

Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs

OUR SUPPORTS

SPARTHA Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM and our partners in the ongoing | PANBioRa project.
We are incubated in | SEMIA and financially supported by | Grand Est region (Start-up support) and | French Public Bank of Investment (BPI, i-Lab 2019)

PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION

TAKE A LOOK AT OUR LATEST NEWS

Interview Business Inside | Forbes France

Issues and innovations around antibacterial coatings. SPARTHA Medical co-founders, Nihal Engin Vrana (Chief Executive Officer) and Philippe Lavalle (Chief Scientific Officer) have been interviewed by Jean Marc Sylvestre for the business TV show ”Business Inside”, in partnership with Forbes France. … Read More

Featured Post

SPARTHA Medical has been selected among the 100 startups to invest in by Challenges

‘100 startups to invest in’ selection Released each year by the magazine Challenges, the 2021 edition of the ‘100 startups to invest in’ selection has included SPARTHA Medical. The top 100 SPARTHA’s presentation ”Our selection in this ranking marks a … Read More

Featured Post

Bourse French Tech Emergence

Bourse French Tech Emergence We are happy to announce that we have been given Bourse French Tech Emergence by Bpifrance for our work on the development of biocompatible antiviral sprays. We would like to thank all our partners particularly SEMIA … Read More

Featured Post